Skip to main content
CVE:LTY

Liberty Biopharma Competitors

C$2.00
+2.00 (+∞)
(As of 10/10/2018)
Add
Compare
Today's Range
C$2.00
C$2.00
50-Day Range
C$2.00
C$2.00
52-Week Range
C$0.06
C$2.74
Volume700 shs
Average Volume23,286 shs
Market CapitalizationC$21.54 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Liberty Biopharma (CVE:LTY) Vs. CHV, PREV, COM, MYM, CURE, and HALO

Should you be buying LTY stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Liberty Biopharma, including (CHV) (CHV), (PREV) (PREV), 138267 (COM.TO) (COM), 17031 (MYM), Direxion Daily Healthcare Bull 3X Shares (CURE), and Halozyme Therapeutics (HALO).

(CHV) (CNSX:CHV) and Liberty Biopharma (CVE:LTY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and price targets for (CHV) and Liberty Biopharma, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Liberty Biopharma0000N/A

Profitability

This table compares (CHV) and Liberty Biopharma's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
Liberty BiopharmaN/AN/AN/A

Earnings and Valuation

This table compares (CHV) and Liberty Biopharma's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Liberty BiopharmaN/AN/AN/AC($0.16)-12.66

Liberty Biopharma (CVE:LTY) and (PREV) (CNSX:PREV) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Analyst Ratings

This is a summary of current ratings and recommmendations for Liberty Biopharma and (PREV), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Liberty Biopharma0000N/A
(PREV)0000N/A

Profitability

This table compares Liberty Biopharma and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Liberty BiopharmaN/AN/AN/A
(PREV)N/AN/AN/A

Valuation & Earnings

This table compares Liberty Biopharma and (PREV)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liberty BiopharmaN/AN/AN/AC($0.16)-12.66
(PREV)N/AN/AN/AN/AN/A

Liberty Biopharma (CVE:LTY) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Profitability

This table compares Liberty Biopharma and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Liberty BiopharmaN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for Liberty Biopharma and 138267 (COM.TO), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Liberty Biopharma0000N/A
138267 (COM.TO)0000N/A

Earnings and Valuation

This table compares Liberty Biopharma and 138267 (COM.TO)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liberty BiopharmaN/AN/AN/AC($0.16)-12.66
138267 (COM.TO)N/AN/AN/AN/AN/A

Liberty Biopharma (CVE:LTY) and 17031 (CNSX:MYM) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.

Profitability

This table compares Liberty Biopharma and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Liberty BiopharmaN/AN/AN/A
17031N/AN/AN/A

Earnings & Valuation

This table compares Liberty Biopharma and 17031's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liberty BiopharmaN/AN/AN/AC($0.16)-12.66
17031N/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Liberty Biopharma and 17031, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Liberty Biopharma0000N/A
170310000N/A

Liberty Biopharma (CVE:LTY) and Direxion Daily Healthcare Bull 3X Shares (CNSX:CURE) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.

Earnings & Valuation

This table compares Liberty Biopharma and Direxion Daily Healthcare Bull 3X Shares' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liberty BiopharmaN/AN/AN/AC($0.16)-12.66
Direxion Daily Healthcare Bull 3X SharesN/AN/AN/AN/AN/A

Profitability

This table compares Liberty Biopharma and Direxion Daily Healthcare Bull 3X Shares' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Liberty BiopharmaN/AN/AN/A
Direxion Daily Healthcare Bull 3X SharesN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Liberty Biopharma and Direxion Daily Healthcare Bull 3X Shares, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Liberty Biopharma0000N/A
Direxion Daily Healthcare Bull 3X Shares0000N/A

Halozyme Therapeutics (NEO:HALO) and Liberty Biopharma (CVE:LTY) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Halozyme Therapeutics and Liberty Biopharma, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Halozyme Therapeutics00014.00
Liberty Biopharma0000N/A

Halozyme Therapeutics currently has a consensus price target of C$0.24, suggesting a potential upside of ∞. Given Halozyme Therapeutics' higher probable upside, research analysts plainly believe Halozyme Therapeutics is more favorable than Liberty Biopharma.

Earnings and Valuation

This table compares Halozyme Therapeutics and Liberty Biopharma's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Halozyme TherapeuticsC$331.26 million0.00C$160.33 millionC$1.13N/A
Liberty BiopharmaN/AN/AN/AC($0.16)-12.66

Halozyme Therapeutics has higher revenue and earnings than Liberty Biopharma. Liberty Biopharma is trading at a lower price-to-earnings ratio than Halozyme Therapeutics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Halozyme Therapeutics and Liberty Biopharma's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Halozyme TherapeuticsN/AN/AN/A
Liberty BiopharmaN/AN/AN/A

Summary

Halozyme Therapeutics beats Liberty Biopharma on 5 of the 5 factors compared between the two stocks.


Liberty Biopharma Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
HALO
Halozyme Therapeutics
1.7N/AN/AC$0.00C$331.26 million47.29Earnings Announcement
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
SCYB
Scythian Biosciences
0.5$3.49+6.3%C$0.00N/A0.00High Trading Volume
ABCN
VIVO Cannabis
0.6$1.32+5.3%C$0.00N/A0.00Gap Up
VP
Vodis Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
This page was last updated on 5/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.